Acta Scientific Medical Sciences (ASMS)(ISSN: 2582-0931)

Opinion Volume 10 Issue 2

Overview of Fatty Liver Disease

Shankar Prasad Bhattacharya

Associate Professor, Community Medicine, MJNMC, Coochbehar, West Bengal, India

*Corresponding Author: Shankar Prasad Bhattacharya, Associate Professor, Community Medicine, MJNMC, Coochbehar, West Bengal, India.

Received: October 09, 2025; Published: January 09, 2026

Abstract

Fatty Liver Disease refers to the abnormal accumulation of fat in the liver cells. When this occurs without significant alcohol intake, it is termed Non-alcoholic Fatty Liver Disease (NAFLD) — recently reclassified as Metabolic dysfunction-associated steatotic liver disease (MASLD) in international consensus to emphasize its metabolic roots. NAFLD/MASLD ranges from simple steatosis to non- alcoholic steatohepatitis (NASH), which may progress to fibrosis, cirrhosis and hepatocellular carcinoma. The condition is closely linked to metabolic syndrome components including obesity, insulin resistance, and dyslipidaemia. Globally, NAFLD has become the most common chronic liver disease, influencing health outcomes and healthcare systems across high- and low-income countries alike due to lifestyle changes, sedentary behaviour and rising prevalence of diabetes and obesity. Early detection and lifestyle intervention are crucial, as progression can lead to irreversible liver damage and increased cardiometabolic risk.

 Keywords: Fatty Liver Disease; Non-alcoholic Fatty Liver Disease (NAFLD); MASLD; Metabolic Dysfunction; Steatosis; Cirrhosis; Metabolic Syndrome; Obesity; Diabetes

References

  1. “Non-alcoholic Fatty Liver Disease (NAFLD) — global and Indian prevalence overview, including burden and outcomes”.
  2. Prevalence of NAFLD in India: Systematic Review & Meta-analysis — pooled estimate of adult and pediatric NAFLD prevalence.
  3. “Cross-sectional and community-based studies on NAFLD prevalence in Indian populations (urban & rural)”.
  4. “Reports describing associations of NAFLD with metabolic conditions, obesity and diabetes”.
  5. “Recent Indian health news and expert insights highlighting silent epidemic, lifestyle risk factors and rising incidence”.

Citation

Citation: Shankar Prasad Bhattacharya. “Overview of Fatty Liver Disease". Acta Scientific Medical Sciences 10.2 (2026): 05-06.

Copyright

Copyright: © 2026 Shankar Prasad Bhattacharya. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.403

Indexed In





Contact US